Literature DB >> 35143020

Gray matter alteration in medication overuse headache: a coordinates-based activation likelihood estimation meta-analysis.

Wenjia Chen1,2, Hui Li3,4, Xiaoyan Hou5, Xize Jia6.   

Abstract

Medication overuse headache (MOH) is a prevalent secondary headache, bringing heavy economic burden and neuropsychological damage. Neuroimaging studies on the disease reported divergent results. To merge the reported neuroimaging alterations in MOH patients and explore a pathophysiological mechanism of this disorder. A meta-analytic activation likelihood estimation (ALE) analysis method was used. We systematically searched English and Chinese databases for both morphological and functional neuroimaging studies published before Nov 18, 2021. Reported altered brain regions and the stereotactic coordinates of their peaks were extracted and pooled by GingerALE using Gaussian probability distribution into brain maps, illustrating converged regions of alteration among studies. We identified 927 articles, of which five studies on gray matter changes, using voxel-based morphometry (VBM) were eventually included for ALE analysis, with 344 subjects and 54 coordinates put into GingerALE. No functional magnetic resonance imaging (fMRI) or positron emission topography (PET) studies were included for pooling. Compared with healthy controls (HCs), MOH featured increased gray matter density in midbrain, striatum, cingulate, inferior parietal cortex and cerebellum (P < 0.001 uncorrected), whereas decreased gray matter density in orbitofrontal cortex (P < 0.05, family-wise error), frontal, insular and parietal cortices (P < 0.001 uncorrected). Withdrawal of analgesics led to decreased gray matter density in superior temporal gyrus, cuneus, midbrain and cerebellum (P < 0.001 uncorrected). This meta-analysis confirmed that medication overuse headache is associated with morphologic alteration in the reward system, the prefrontal cortex and a reversible modification in the pain network. Further functional imaging paradigms and longitudinal studies are required for a more definite conclusion and a causal mechanism.
© 2022. The Author(s).

Entities:  

Keywords:  ALE; Detoxification; Gray matter; Medication overuse headache; VBM

Mesh:

Year:  2022        PMID: 35143020      PMCID: PMC9581858          DOI: 10.1007/s11682-022-00634-9

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.224


  49 in total

1.  Thresholding of statistical maps in functional neuroimaging using the false discovery rate.

Authors:  Christopher R Genovese; Nicole A Lazar; Thomas Nichols
Journal:  Neuroimage       Date:  2002-04       Impact factor: 6.556

Review 2.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

3.  Grey matter changes associated with medication-overuse headache: correlations with disease related disability and anxiety.

Authors:  Franz Riederer; Marvin Marti; Roger Luechinger; Rupert Lanzenberger; Jan von Meyenburg; Andreas R Gantenbein; Roberto Pirrotta; Charly Gaul; Spyridon Kollias; Peter S Sándor
Journal:  World J Biol Psychiatry       Date:  2012-07-02       Impact factor: 4.132

Review 4.  Orbitofrontal cortex and human drug abuse: functional imaging.

Authors:  E D London; M Ernst; S Grant; K Bonson; A Weinstein
Journal:  Cereb Cortex       Date:  2000-03       Impact factor: 5.357

5.  Gray matter changes related to medication overuse in patients with chronic migraine.

Authors:  Tzu-Hsien Lai; Kung-Hsien Chou; Jong-Ling Fuh; Pei-Lin Lee; Yi-Chia Kung; Ching-Po Lin; Shuu-Jiun Wang
Journal:  Cephalalgia       Date:  2016-02-06       Impact factor: 6.292

Review 6.  Nucleus accumbens shell and core dopamine: differential role in behavior and addiction.

Authors:  Gaetano Di Chiara
Journal:  Behav Brain Res       Date:  2002-12-02       Impact factor: 3.332

7.  Altered experimental pain perception after cerebellar infarction.

Authors:  Ruth Ruscheweyh; Maria Kühnel; Filipp Filippopulos; Bernhard Blum; Thomas Eggert; Andreas Straube
Journal:  Pain       Date:  2014-04-08       Impact factor: 6.961

8.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-08       Impact factor: 79.321

9.  Cortical and Subcortical Alterations in Medication Overuse Headache.

Authors:  Jan Mehnert; Julia Hebestreit; Arne May
Journal:  Front Neurol       Date:  2018-06-25       Impact factor: 4.003

10.  Dissociated grey matter changes with prolonged addiction and extended abstinence in cocaine users.

Authors:  Colm G Connolly; Ryan P Bell; John J Foxe; Hugh Garavan
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.